Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity

[1] Popovich RP(1999)Continuous ambulatory peritoneal dialysis. 1978 J Am Soc Nephrol 10 901-910

[2] Moncrief JW(1978)A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD) Trans Am Soc Artif Intern Organs 24 484-489

[3] Nolph KD(2008)Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology Clin J Am Soc Nephrol 3 720-728

[4] Ghods AJ(2013)Peritoneal changes in patients on long-term peritoneal dialysis Nat Rev Nephrol 9 419-429

[5] Twardowski ZJ(2005)Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures Perit Dial Int 25 S83-S95

[6] Pyle WK(2011)Encapsulating peritoneal sclerosis: the state of affairs Nat Rev Nephrol 7 528-538

[7] Oreopoulos DG(2014)Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan Int J Urol 21 755-761

[8] Robson M(2016)Preventing peritoneal membrane fibrosis in peritoneal dialysis patients Kidney Int 90 515-524

[9] Izatt S(2009)Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution Perit Dial Int 29 S21-S27

[10] Clayton S(2011)The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int 79 814-824

[1] Popovich RP(1999)Continuous ambulatory peritoneal dialysis. 1978 J Am Soc Nephrol 10 901-910

[2] Moncrief JW(1978)A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD) Trans Am Soc Artif Intern Organs 24 484-489

[3] Nolph KD(2008)Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology Clin J Am Soc Nephrol 3 720-728

[4] Ghods AJ(2013)Peritoneal changes in patients on long-term peritoneal dialysis Nat Rev Nephrol 9 419-429

[5] Twardowski ZJ(2005)Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures Perit Dial Int 25 S83-S95

[6] Pyle WK(2011)Encapsulating peritoneal sclerosis: the state of affairs Nat Rev Nephrol 7 528-538

[7] Oreopoulos DG(2014)Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan Int J Urol 21 755-761

[8] Robson M(2016)Preventing peritoneal membrane fibrosis in peritoneal dialysis patients Kidney Int 90 515-524

[9] Izatt S(2009)Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution Perit Dial Int 29 S21-S27

[10] Clayton S(2011)The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int 79 814-824